|
|
||||||||
CUTTING EDGE |


* Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215;
Department of Cellular Biology and Pathology, Immunology Unit, Medical School, University of Barcelona, Barcelona, Spain; and
Department of Microbiology, Division of Graduate Medical Sciences, Boston University School of Medicine, Boston, MA 02118
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In addition to sensing the presence of bacteria, the innate immune system has also developed several strategies for killing and processing bacteria as well as presenting their antigenic components to the adaptive immune system for subsequent humoral responses (6, 7). One of the key methods in which phagocytic cells are able to efficiently kill engulfed bacteria is through the production of bactericidal reactive oxygen species (ROS;3 superoxide; O ![]()
Although it is well appreciated that both MyD88 and NADPH oxidase each contribute to the sensing and resolution of bacterial infection (1, 2, 5, 6, 13), it is as yet unclear and, in some cases, controversial (14, 15, 16), if and how these two individually studied components of innate immunity interact in phagocytic cells. The study reported here was conducted to determine whether MyD88 deficiency would alter NADPH oxidase activity and consequently bacterial killing.
| Materials and Methods |
|---|
|
|
|---|
Elicited macrophages were obtained from wild-type C57BL/6 (The Jackson Laboratory) and MyD88/ (B6.129P2-MyD88tm1Aki) mice by i.p. injection of 2 ml of 4% sterile Brewers thioglycolate medium. On the fifth day postinjection, peritoneal lavage was performed with 20 ml of ice-cold RPMI 1640 supplemented with 5% FCS. Cells were washed three times with RPMI 1640/5% FCS before enumeration and plating.
Neutrophils were isolated from bone marrow as described previously (17). Briefly, bone marrow was washed three times in HBSS supplemented with 5% FCS and neutrophils were then isolated by discontinuous Percoll gradient centrifugation. Cells suspended in 2 ml of HBSS were layered on the top of a 15-ml conical tube containing a gradient consisting of (bottom to top) 4 ml of 75% Percoll in PBS, 3 ml of 65% Percoll, and 3 ml of 55% Percoll. The gradient was centrifuged at 1600 rpm for 30 min. Neutrophils were isolated from the 75/65 interface, washed, and enumerated. Using this technique, >95% purity was routinely obtained as assessed by Wright-Giemsa staining.
Gentamicin protection assay
Macrophage bactericidal activity was measured using a gentamicin protection assay. Macrophages were plated in 24-well plates at 1 x 106/well in triplicate for each condition and time point. Cells were incubated with bacteria at a 10:1 ratio of bacteria:macrophages for 1 h at 37°C to allow phagocytosis to occur. After 1 h, gentamicin was added to the medium at 100 µg/ml for 1 h to kill extracellular bacteria. At 2 h, the medium was replaced with fresh medium containing 10 µg/ml gentamicin. At 2, 6, and 24 h, cells were washed with PBS and lysed with 1 ml of 0.5% Triton X-100 in sterile water for 15 min at room temperature. Various dilutions were plated directly onto Lennox-Bertani agar plates and colonies were counted after overnight incubation at 37°C.
Flow cytometric measurement of macrophage phagocytosis
Peritoneal macrophages (4 x 106/ml in HBSS supplemented with 5% FCS) were incubated for various periods with 4 x 108 paraformaldehyde-fixed and opsonized GFP-expressing Escherichia coli strain MS589 (a gift from Dr. P. Klemm, Technical University of Denmark Lyngby, Denmark) or 4 x 108 fixed and opsonized GFP-expressing Salmonella typhimurium strain sseB (a gift from Dr. M. E. H. Bashir, Massachusetts General Hospital, Boston MA). Following incubation cells were washed three times in ice-cold PBS followed by a 60-s wash in 0.4% trypan blue to quench extracellular GFP and a final wash in PBS before data acquisition on a FACScan flow cytometer (BD Biosciences). As a negative control for nonspecific bacterial adhesion, a portion of the macrophages were fixed for 10 min in 2% paraformaldehyde before the assay.
Measurement of superoxide generation
Neutrophil and macrophage superoxide production was measured with the fluorogenic substrate lucigenin. Neutrophils and macrophages were resuspended in HBSS with 5% FCS at 2.5 x 105 and 1 x 106/ml, respectively. Cells were stimulated for 2 h with 8 x 107 heat-killed, opsonized E. coli or S. typhimurium. Alternatively, to measure maximal receptor-independent ROS production, cells were stimulated with PMA (Sigma-Aldrich) at 1 µg/ml. Luminescence was measured at various time points throughout the stimulations with a TD2020 luminometer (Turner Designs).
| Results and Discussion |
|---|
|
|
|---|
Since MyD88 plays a pivotal role in TLR-mediated signaling, we wished to determine whether deficiency in this key adaptor protein impacted the ability of peritoneal macrophages to kill Gram-negative bacteria upon phagocytosis. As shown in Fig. 1, A and B, MyD88/ macrophages are severely impaired in killing both commensal and attenuated pathogenic Gram-negative bacteria (i.e., F18 E. coli and the sseB variant of S. typhimurium, respectively) as judged using the in vitro gentamicin protection assay. This defect in bacterial killing was not due to either impaired phagocytosis of bacteria, because both wild-type and MyD88/ macrophages engulfed GFP-expressing E. coli and S. typhimurium sseB with similar efficiencies (Fig. 1C) or differences in the activation state of the macrophages as assessed by surface marker expression (TLR-4, MHC class II, F4/80, Mac-1, and CD11c; data not shown). This is in contrast to a recent study showing that MyD88/ macrophages have impaired phagocytic capacity (18). The difference between our findings may be due to the use of bone marrow-derived macrophages (18) vs primary elicited macrophages used in this study.
|
![]()
|
We conclude that macrophages and neutrophils derived from mice that are deficient in the TLR adaptor protein MyD88 are impaired in their ability to kill bacteria. This killing defect arises as a result of impaired NADPH oxidase function.
Assembly of the NADPH oxidase enzyme complex is impaired in MyD88/ phagocytes
We next determined whether the observed defect in ROS production in MyD88/ macrophages was due to impaired activity or assembly. To this end, wild-type and MyD88/ peritoneal macrophages were examined for distribution of both the membrane-bound p22phox protein and the cytosolic p47phox component of NADPH oxidase after exposure to GFP-expressing E. coli. As shown in Fig. 3, clustering of p22phox to bacteria-containing phagosomes is impaired in the MyD88/ macrophages (Fig. 3, upper panels). In addition, mobilization of cytosolic p47phox to bacteria-containing vesicles is also inefficient in MyD88/ cells (Fig. 3, lower panels). This suggests that a defect in assembly is the underlying cause of reduced ROS production by the NADPH oxidase enzyme complex in MyD88-deficient phagocytes.
|
It is well appreciated that serine phosphorylation of the cytosolic components of NADPH oxidase, particularly p47phox, is required for mobilization to the membrane-bound cytochrome b558 (i.e., gp91-p22phox) complex and subsequent production of ROS by NADPH oxidase. Since a defect in assembly of NADPH oxidase in MyD88/ macrophages was apparent, we next determined whether this was due to impairment of one or more of the signaling cascades known to play a role in oxidase assembly via phosphorylation of p47phox (11, 12, 19, 20). To this end, we examined macrophage responses to whole bacteria, which is considered more physiologically relevant, while using LPS stimulation as a reference. Examining levels of phospho-p47phox in response to bacteria, we found that although wild-type macrophages show a robust up-regulation, MyD88/ macrophages were unable to increase the level of phospho-p47phox relative to the unstimulated state (Fig. 4A). This correlated with a lack of up-regulation of p38 MAPK activity in MyD88/ macrophages exposed to bacteria (Fig. 4B, top). As with functional superoxide generation (Fig. 2), lack of p38 MAPK activation in response to bacteria was not intrinsic to MyD88/ macrophages because PMA stimulation induced similar levels of phospho-p38 MAPK in both wild-type and MyD88/ macrophages (Fig. 4B, bottom). This was indirectly confirmed by studies showing that the residual NADPH oxidase activity of MyD88/ macrophages was largely insensitive to p38 MAPK kinase inhibitors (Fig. 4C).
|
B
degradation and activation of the SAPK/JNK pathway, both of which are important for cytokine production, are also impaired in MyD88/ macrophages following exposure to Gram-negative bacteria (data not shown). The latter suggests that MyD88 plays a role not only in the immediate oxidant-mediated killing of bacteria, but also in later cytokine-mediated events important for resolution of infection. Taken together, the results of this study demonstrate a previously unappreciated role for MyD88, and potentially other TLR adaptor proteins, in mediating killing of intracellular bacteria via influencing assembly and thus activity of the NADPH oxidase complex. As such, further study of the mechanisms underlying the interplay between TLR adaptor proteins and oxidant-producing enzyme complexes would contribute greatly to our understanding of how the innate immune system resolves bacterial infection as well as form a basis for the development of therapeutic strategies to enhance clearance of pathogenic bacteria.
| Acknowledgments |
|---|
| Disclosures |
|---|
|
|
|---|
| Footnotes |
|---|
1 This work was supported by National Institutes of Health Grants DK52510 and AI15066. F.S.L. is supported by National Institutes of Health Grant 5T32 DK07760. ![]()
2 Address correspondence and reprint requests to Dr. Cox Terhorst, Division of Immunology HIM 817, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215. E-mail address: terhors{at}caregroup.harvard.edu ![]()
3 Abbreviation used in this paper: ROS, reactive oxygen species. ![]()
Received for publication June 9, 2005. Accepted for publication September 20, 2005.
| References |
|---|
|
|
|---|
B. J. Immunol. 173:3589.-3593.
B and interleukin-8 expression. Infect. Immun. 72:2123.-2130.
but not Akt. Biochem. Biophys. Res. Commun. 316:720.-730. [Medline]This article has been cited by other articles:
![]() |
L. Shi, S. M. Chowdhury, H. S. Smallwood, H. Yoon, H. M. Mottaz-Brewer, A. D. Norbeck, J. E. McDermott, T. R. W. Clauss, F. Heffron, R. D. Smith, et al. Proteomic Investigation of the Time Course Responses of RAW 264.7 Macrophages to Infection with Salmonella enterica Infect. Immun., August 1, 2009; 77(8): 3227 - 3233. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. S. Shin, L. S. Miller, R. L. Modlin, S. Akira, S. Uematsu, and L. T. Hu Downstream Signals for MyD88-Mediated Phagocytosis of Borrelia burgdorferi Can Be Initiated by TRIF and Are Dependent on PI3K J. Immunol., July 1, 2009; 183(1): 491 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Boots, M. Hristova, D. I. Kasahara, G. R. M. M. Haenen, A. Bast, and A. van der Vliet ATP-mediated Activation of the NADPH Oxidase DUOX1 Mediates Airway Epithelial Responses to Bacterial Stimuli J. Biol. Chem., June 26, 2009; 284(26): 17858 - 17867. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, Y. Jia, M. Pichavant, F. Loison, B. Sarraj, A. Kasorn, J. You, B. E. Robson, D. T. Umetsu, J. P. Mizgerd, et al. Targeted deletion of tumor suppressor PTEN augments neutrophil function and enhances host defense in neutropenia-associated pneumonia Blood, May 14, 2009; 113(20): 4930 - 4941. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, V. Canadien, G. Y. Lam, B. E. Steinberg, M. C. Dinauer, M. A. O. Magalhaes, M. Glogauer, S. Grinstein, and J. H. Brumell Activation of antibacterial autophagy by NADPH oxidases PNAS, April 14, 2009; 106(15): 6226 - 6231. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Ko, J.-Y. Yang, D.-H. Shim, H. Yang, S.-M. Park, R. Curtiss III, and M.-N. Kweon Innate Immunity Mediated by MyD88 Signal Is Not Essential for Induction of Lipopolysaccharide-Specific B Cell Responses but Is Indispensable for Protection against Salmonella enterica serovar Typhimurium infection J. Immunol., February 15, 2009; 182(4): 2305 - 2312. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sundquist and M. J. Wick Salmonella induces death of CD8{alpha}+ dendritic cells but not CD11cintCD11b+ inflammatory cells in vivo via MyD88 and TNFR1 J. Leukoc. Biol., February 1, 2009; 85(2): 225 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Park, H.-J. Ko, D.-H. Shim, J.-Y. Yang, Y.-H. Park, R. Curtiss III, and M.-N. Kweon MyD88 Signaling Is Not Essential for Induction of Antigen-Specific B Cell Responses but Is Indispensable for Protection against Streptococcus pneumoniae Infection following Oral Vaccination with Attenuated Salmonella Expressing PspA Antigen J. Immunol., November 1, 2008; 181(9): 6447 - 6455. [Abstract] [Full Text] [PDF] |
||||
![]() |
P-R. Burgel and J. A. Nadel Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases Eur. Respir. J., October 1, 2008; 32(4): 1068 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. S. Shin, R. R. Isberg, S. Akira, S. Uematsu, A. K. Behera, and L. T. Hu Distinct Roles for MyD88 and Toll-Like Receptors 2, 5, and 9 in Phagocytosis of Borrelia burgdorferi and Cytokine Induction Infect. Immun., June 1, 2008; 76(6): 2341 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Charles, M. B. Humphrey, X. Zhao, E. Quarles, M. C. Nakamura, A. Aderem, W. E. Seaman, and K. D. Smith The Innate Immune Response to Salmonella enterica Serovar Typhimurium by Macrophages Is Dependent on TREM2-DAP12 Infect. Immun., June 1, 2008; 76(6): 2439 - 2447. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Into, M. Inomata, M. Nakashima, K.-i. Shibata, H. Hacker, and K. Matsushita Regulation of MyD88-Dependent Signaling Events by S Nitrosylation Retards Toll-Like Receptor Signal Transduction and Initiation of Acute-Phase Immune Responses Mol. Cell. Biol., February 15, 2008; 28(4): 1338 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Bailey, H. Engler, N. D. Powell, D. A. Padgett, and J. F. Sheridan Repeated social defeat increases the bactericidal activity of splenic macrophages through a Toll-like receptor-dependent pathway Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1180 - R1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. van Bruggen, D. Zweers, A. van Diepen, J. T. van Dissel, D. Roos, A. J. Verhoeven, and T. W. Kuijpers Complement Receptor 3 and Toll-Like Receptor 4 Act Sequentially in Uptake and Intracellular Killing of Unopsonized Salmonella enterica Serovar Typhimurium by Human Neutrophils Infect. Immun., June 1, 2007; 75(6): 2655 - 2660. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fan, Y. Li, R. M. Levy, J. J. Fan, D. J. Hackam, Y. Vodovotz, H. Yang, K. J. Tracey, T. R. Billiar, and M. A. Wilson Hemorrhagic Shock Induces NAD(P)H Oxidase Activation in Neutrophils: Role of HMGB1-TLR4 Signaling J. Immunol., May 15, 2007; 178(10): 6573 - 6580. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakanaga, J. A. Nadel, I. F. Ueki, J. L. Koff, and M. X. G. Shao Regulation of interleukin-8 via an airway epithelial signaling cascade Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1289 - L1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Miletic, D. B. Graham, V. Montgrain, K. Fujikawa, T. Kloeppel, K. Brim, B. Weaver, R. Schreiber, R. Xavier, and W. Swat Vav proteins control MyD88-dependent oxidative burst Blood, April 15, 2007; 109(8): 3360 - 3368. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Crawford, C. V. Aylott, R. W. Bourdeau, and G. M. Bokoch Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity. J. Immunol., June 15, 2006; 176(12): 7557 - 7565. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sancho-Shimizu and D. Malo Sequencing, Expression, and Functional Analyses Support the Candidacy of Ncf2 in Susceptibility to Salmonella Typhimurium Infection in Wild-Derived Mice. J. Immunol., June 1, 2006; 176(11): 6954 - 6961. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |